Streetbeat News

Equity Actions

CHTR

Charter Communications (NASDAQ:CHTR) is evaluated against its major competitors in the Media industry. The company has a lower Price to Earnings ratio, suggesting potential undervaluation, but a higher Price to Book ratio, indicating possible overvaluation. It also has a higher Return on Equity, EBITDA, and revenue growth, suggesting strong profitability and growth potential. However, its gross profit is relatively low, and it has a higher debt-to-equity ratio, indicating greater financial risk.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 4:00 pm

CDW

The article provides a comprehensive comparison of CDW Corp (NASDAQ:CDW) with its competitors in the Electronic Equipment, Instruments & Components industry. CDW's P/E, P/B, and P/S ratios are significantly higher than the industry average, indicating a premium valuation. The company's ROE and EBITDA are also above average, suggesting efficient use of equity and strong profitability. However, CDW's revenue growth is below the industry average, indicating potential struggles in increasing sales volume. CDW also has a higher debt-to-equity ratio than its peers, implying a greater reliance on debt financing.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 4:00 pm

AMPL

Amplitude (NASDAQ:AMPL) CEO Spenser Skates advocates for a relentless pursuit of the best possible outcome in business endeavors, contrary to the well-known business adage that warns against letting 'perfect' be the enemy of 'good.' This attitude has benefited Amplitude, a company currently valued at $1.4 billion. Skates and his colleague Curtis Liu leveraged their technology from voice recognition startup Sonalight to establish Amplitude, which they felt had a brighter future.

Portfolio Pulse from Bibhu Pattnaik

November 06, 2023 | 3:53 pm

AZN

AstraZeneca Inc.'s (NASDAQ:AZN) share price is currently at $64.33, after a 0.58% increase. Over the past month, the stock decreased by 5.44%, but in the past year, it went up by 4.86%. The company's P/E ratio is 32.38, higher than the aggregate P/E ratio of the Pharmaceuticals industry (30.48), indicating that the stock might be overvalued. The P/E ratio is a useful metric for analyzing a company's market performance, but it should not be used in isolation.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:30 pm

CELH

Celsius Holdings Inc (NASDAQ:CELH) shares are trading higher due to continued momentum after the company announced a three-for-one stock split last week. The company is also set to report earnings before the market opens on Tuesday. Analysts expect the company to report earnings of 47 cents per share and revenue of $349.549 million.

Portfolio Pulse from Adam Eckert

November 06, 2023 | 3:07 pm

MU

Micron Technology, Inc (NASDAQ:MU) plans to manufacture advanced AI memory chips in Taiwan and Japan. Taiwan will be the first location to produce Micron's next generation 1-gamma node dynamic random-access memory (DRAM) chips in 2025. The company will later expand production to Japan. These chips enable powerful generative AI computing applications. Meanwhile, China's commerce minister has welcomed Micron to consolidate its foothold in the Chinese market.

Portfolio Pulse from Anusuya Lahiri

November 06, 2023 | 2:26 pm

NRG

NRG Energy has announced a $950 million accelerated share repurchase program. This move is expected to return value to shareholders and potentially boost the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:23 pm

GOLD

Barrick Gold Corporation (NYSE:GOLD) has agreed to subscribe for 21,265,370 units of Hercules Silver Corp. in a non-brokered private placement at a price of $1.10 per unit, for a total consideration of $23,391,907. Post the placement, Barrick will hold approximately 12.33% of Hercules' issued and outstanding common shares on a non-diluted basis, and 15.02% on a partially-diluted basis. The deal includes an investor rights agreement, granting Barrick anti-dilution and information rights, and a right of first refusal in respect of the sale by Hercules of any interest in its Hercules Silver Project.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:18 pm

AUMN

Golden Minerals Company (NYSE:AUMN, TSX:AUMN) has announced the pricing of its public offering of 6,000,000 shares of common stock and Series A and B warrants to purchase up to 9,000,000 shares of common stock, at a price of $0.70 per share. The offering is expected to close on November 8, 2023, and is expected to raise approximately $4.2 million. The proceeds will be used for working capital and other general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:16 pm

LMDX

LumiraDx has appointed Lurene Joseph and George Neble, both current independent members of the board, as co-chairpersons of the board, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:15 pm